CRADD antibody
Quick Overview for CRADD antibody (ABIN7266106)
Target
See all CRADD AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- RAIDD/CRADD Rabbit mAb
-
Cross-Reactivity
- Human, Rat
-
Characteristics
- Monoclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- A synthesized peptide derived from human RAIDD/CRADD
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000,IF,1:50 - 1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- CRADD (CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD))
-
Alternative Name
- CRADD
-
Background
- This gene encodes a protein containing a death domain (DD) motif. This protein recruits caspase 2/ICH1 to the cell death signal transduction complex, which includes tumor necrosis factor receptor 1 (TNFR1A) and RIPK1/RIP kinase, and acts in promoting apoptosis. A mutation in this gene was associated with mental retardation. A related pseudogene is found on chromosome 3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016],MRT34, RAIDD,Apoptosis,Apoptosis_Mitochondrial Control of Apoptosis,Cancer,Cell Biology & Developmental Biology,Death Receptor Signaling Pathway,Invasion and Metastasis,CRADD
-
Molecular Weight
- 23kDa
-
Gene ID
- 8738
-
UniProt
- P78560
-
Pathways
- Apoptosis, Caspase Cascade in Apoptosis, Positive Regulation of Endopeptidase Activity
Target
-